Ana Casbas-Gutierrez
Hospital Universitario Dr. Balmis De Alicante
Alicante, VC, Spain
Alicante, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Position statement of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the diagnosis and management of acute severe ulcerative colitis.
Journal: Gastroenterologia y hepatologia
Published: May 05, 2026
Positioning Guselkumab in The Treatment Algorithm for Ulcerative Colitis.
Journal: Journal of inflammation research
Published: February 19, 2026
Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral.
Journal: Dermatology and therapy
Published: February 06, 2026
Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry.
Journal: United European gastroenterology journal
Published: February 01, 2026
Etrasimod: Review of the safety and practical management considerations of a new oral therapy for the treatment of ulcerative colitis.
Journal: Gastroenterologia y hepatologia
Published: October 13, 2025
Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin.
Journal: Annals of the rheumatic diseases
Published: June 29, 2025
GETECCU position paper on fragility, advanced age and inflammatory bowel disease.
Journal: Gastroenterologia y hepatologia
Published: June 26, 2025
Prevalence of Undiagnosed Inflammatory Bowel Disease in Spondyloarthritis Patients.
Journal: Journal of clinical medicine
Published: May 08, 2025
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU.
Journal: Journal of Crohn's & colitis
Published: April 10, 2025
Spanish Working Group in Crohn's Disease and Ulcerative Colitis (GETECCU) position paper for the management of non-perianal fistulizing Crohn's disease.
Journal: Gastroenterologia y hepatologia
Published: April 09, 2025
EVOLVE-IBERIA: Real-world evidence on vedolizumab and anti-tumor necrosis factor-α as first- or second-line biologic treatment among patients with ulcerative colitis.
Journal: Gastroenterologia y hepatologia
Published: April 02, 2025
Psychomotor Development in Infants Following Maternal Exposure to Biologics: Results From the DUMBO Registry.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: March 31, 2025
Last Updated: 09/26/2026